Premium
Letter: ciclosporin and vedolizumab for steroid‐refractory ulcerative colitis
Author(s) -
Resál Tamás,
Pigniczki Daniella,
Szántó Kata,
Rutka Mariann,
Farkas Klaudia,
Molnar Tamas
Publication year - 2020
Publication title -
alimentary pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.308
H-Index - 177
eISSN - 1365-2036
pISSN - 0269-2813
DOI - 10.1111/apt.15896
Subject(s) - vedolizumab , medicine , ulcerative colitis , ciclosporin , refractory (planetary science) , colitis , dermatology , gastroenterology , chemotherapy , disease , physics , astrobiology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom